Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

History of the Discovery of Hepatitis A Virus.

Feinstone SM.

Cold Spring Harb Perspect Med. 2019 May 1;9(5). pii: a031740. doi: 10.1101/cshperspect.a031740. Review.

PMID:
29712682
2.

Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model.

Carpentier A, Tesfaye A, Chu V, Nimgaonkar I, Zhang F, Lee SB, Thorgeirsson SS, Feinstone SM, Liang TJ.

J Clin Invest. 2014 Nov;124(11):4953-64. doi: 10.1172/JCI75456. Epub 2014 Oct 8.

3.

Chimeric mouse model for the infection of hepatitis B and C viruses.

Tesfaye A, Stift J, Maric D, Cui Q, Dienes HP, Feinstone SM.

PLoS One. 2013 Oct 14;8(10):e77298. doi: 10.1371/journal.pone.0077298. eCollection 2013.

4.

The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

Shin EC, Park SH, Nascimbeni M, Major M, Caggiari L, de Re V, Feinstone SM, Rice CM, Rehermann B.

J Virol. 2013 Apr;87(8):4772-7. doi: 10.1128/JVI.03122-12. Epub 2013 Feb 6.

5.

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.

Feinstone SM, Hu DJ, Major ME.

Clin Infect Dis. 2012 Jul;55 Suppl 1:S25-32. doi: 10.1093/cid/cis362. Review.

PMID:
22715210
6.

Selection of hepatitis C virus resistant to ribavirin.

Feigelstock DA, Mihalik KB, Feinstone SM.

Virol J. 2011 Aug 15;8:402. doi: 10.1186/1743-422X-8-402.

7.

Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C.

Shin EC, Park SH, Demino M, Nascimbeni M, Mihalik K, Major M, Veerapu NS, Heller T, Feinstone SM, Rice CM, Rehermann B.

Gastroenterology. 2011 Aug;141(2):686-95, 695.e1. doi: 10.1053/j.gastro.2011.05.006. Epub 2011 May 18.

8.

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Dahari H, Feinstone SM, Major ME.

Gastroenterology. 2010 Sep;139(3):965-74. doi: 10.1053/j.gastro.2010.05.077. Epub 2010 Jun 2.

9.

Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture.

Silberstein E, Mihalik K, Ulitzky L, Plant EP, Puig M, Gagneten S, Yu MY, Kaushik-Basu N, Feinstone SM, Taylor DR.

PLoS Pathog. 2010 May 20;6(5):e1000910. doi: 10.1371/journal.ppat.1000910.

10.

Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models.

Bukh J, Meuleman P, Tellier R, Engle RE, Feinstone SM, Eder G, Satterfield WC, Govindarajan S, Krawczynski K, Miller RH, Leroux-Roels G, Purcell RH.

J Infect Dis. 2010 May 1;201(9):1381-9. doi: 10.1086/651579.

11.

Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I.

Feigelstock DA, Mihalik KB, Kaplan G, Feinstone SM.

Virol J. 2010 Feb 19;7:44. doi: 10.1186/1743-422X-7-44.

12.

Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver.

Shin EC, Seifert U, Urban S, Truong KT, Feinstone SM, Rice CM, Kloetzel PM, Rehermann B.

J Interferon Cytokine Res. 2007 Dec;27(12):985-90. doi: 10.1089/jir.2007.0039.

PMID:
18184038
13.

Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma.

Zhang P, Wu CG, Mihalik K, Virata-Theimer ML, Yu MY, Alter HJ, Feinstone SM.

Proc Natl Acad Sci U S A. 2007 May 15;104(20):8449-54. Epub 2007 May 9.

14.

Evidence for a functional RNA element in the hepatitis C virus core gene.

McMullan LK, Grakoui A, Evans MJ, Mihalik K, Puig M, Branch AD, Feinstone SM, Rice CM.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2879-84. Epub 2007 Feb 13.

15.

Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver.

Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M, Feinstone SM, Thorgeirsson SS.

Hepatology. 2006 Dec;44(6):1478-86.

PMID:
17133486
16.

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection.

Shin EC, Seifert U, Kato T, Rice CM, Feinstone SM, Kloetzel PM, Rehermann B.

J Clin Invest. 2006 Nov;116(11):3006-14. Epub 2006 Oct 12.

17.

CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.

Puig M, Mihalik K, Tilton JC, Williams O, Merchlinsky M, Connors M, Feinstone SM, Major ME.

Hepatology. 2006 Sep;44(3):736-45.

PMID:
16941702
18.

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G, Rice CM.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3805-9. Epub 2006 Feb 16.

19.

Liver-directed gamma interferon gene delivery in chronic hepatitis C.

Shin EC, Protzer U, Untergasser A, Feinstone SM, Rice CM, Hasselschwert D, Rehermann B.

J Virol. 2005 Nov;79(21):13412-20.

20.

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.

Taylor DR, Puig M, Darnell ME, Mihalik K, Feinstone SM.

J Virol. 2005 May;79(10):6291-8.

21.

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.

Dahari H, Major M, Zhang X, Mihalik K, Rice CM, Perelson AS, Feinstone SM, Neumann AU.

Gastroenterology. 2005 Apr;128(4):1056-66.

PMID:
15825086
22.

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.

Darnell ME, Subbarao K, Feinstone SM, Taylor DR.

J Virol Methods. 2004 Oct;121(1):85-91.

PMID:
15350737
24.

Neutralizing antibody response during acute and chronic hepatitis C virus infection.

Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10149-54. Epub 2004 Jun 25.

25.

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.

Major ME, Dahari H, Mihalik K, Puig M, Rice CM, Neumann AU, Feinstone SM.

Hepatology. 2004 Jun;39(6):1709-20.

PMID:
15185313
27.

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.

Yu MY, Bartosch B, Zhang P, Guo ZP, Renzi PM, Shen LM, Granier C, Feinstone SM, Cosset FL, Purcell RH.

Proc Natl Acad Sci U S A. 2004 May 18;101(20):7705-10. Epub 2004 May 10.

28.

Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, Feinstone SM, Rehermann B.

J Virol. 2003 Apr;77(8):4781-93.

30.

The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity.

Thomson M, Nascimbeni M, Havert MB, Major M, Gonzales S, Alter H, Feinstone SM, Murthy KK, Rehermann B, Liang TJ.

J Virol. 2003 Jan;77(2):862-70.

31.

Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay.

Puig M, Mihalik K, Yu MY, Feinstone SM, Major ME.

J Virol Methods. 2002 Sep;105(2):253-63.

PMID:
12270658
32.

Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, Feinstone SM.

J Virol. 2002 Jul;76(13):6586-95.

33.

Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.

Mizukoshi E, Nascimbeni M, Blaustein JB, Mihalik K, Rice CM, Liang TJ, Feinstone SM, Rehermann B.

J Virol. 2002 Jun;76(12):6093-103.

34.

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein.

Moriya O, Matsui M, Osorio M, Miyazawa H, Rice CM, Feinstone SM, Leppla SH, Keith JM, Akatsuka T.

Vaccine. 2001 Dec 12;20(5-6):789-96.

PMID:
11738742
35.

Retraction.

Arichi T, Saito T, Major ME, Belyakov IM, Shirai M, Engelhard VH, Feinstone SM, Berzofsky JA.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5943. Epub 2001 May 1. No abstract available.

36.

Transfusion-associated hepatitis not due to viral hepatitis type A or B. 1975.

Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV.

Rev Med Virol. 2001 Jan-Feb;11(1):3-8; discussion 8-9. No abstract available.

PMID:
11241798
39.

Characterization of hepatitis C virus infectious clones in chimpanzees: long-term studies.

Major ME, Feinstone SM.

Curr Top Microbiol Immunol. 2000;242:279-98. Review. No abstract available.

PMID:
10592665
40.

Molecular analyses of five new chimpanzee MHC class I alleles: implications for differences between evolutional mechanisms of HLA-A, -B, and -C loci.

Matsui M, Machida S, Feinstone SM, Akatsuka T.

Biochem Biophys Res Commun. 1999 Jul 22;261(1):46-52.

PMID:
10405321
41.

Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus.

Major ME, Mihalik K, Fernandez J, Seidman J, Kleiner D, Kolykhalov AA, Rice CM, Feinstone SM.

J Virol. 1999 Apr;73(4):3317-25.

42.

T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.

Shirai M, Arichi T, Chen M, Masaki T, Nishioka M, Ikeda K, Takahashi H, Enomoto N, Saito T, Major ME, Nakazawa T, Akatsuka T, Feinstone SM, Berzofsky JA.

J Immunol. 1999 Jan 1;162(1):568-76. Erratum in: J Immunol 1999 Jul 15;163(2):1093. J Immunol 2001 Dec 15;167(12):7207.

43.

Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.

Sarobe P, Pendleton CD, Akatsuka T, Lau D, Engelhard VH, Feinstone SM, Berzofsky JA.

J Clin Invest. 1998 Sep 15;102(6):1239-48.

44.

FDA "reform"?

Feinstone SM, Lewis AM Jr, Markoff LJ, Carbone K, Golding H.

Science. 1998 Jan 9;279(5348):157-8. No abstract available.

PMID:
9446214
45.

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM.

Science. 1997 Jul 25;277(5325):570-4.

46.

The molecular virology of hepatitis C.

Major ME, Feinstone SM.

Hepatology. 1997 Jun;25(6):1527-38. Review. No abstract available.

PMID:
9185778
47.

Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice.

Saito T, Sherman GJ, Kurokohchi K, Guo ZP, Donets M, Yu MY, Berzofsky JA, Akatsuka T, Feinstone SM.

Gastroenterology. 1997 Apr;112(4):1321-30.

PMID:
9098018
48.

A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2.

Tedeschi V, Akatsuka T, Shih JW, Battegay M, Feinstone SM.

Hepatology. 1997 Feb;25(2):459-62.

PMID:
9021964
49.

Inactivation of hepatitis A and other enteroviruses during heat treatment (pasteurization).

Nissen E, König P, Feinstone SM, Pauli G.

Biologicals. 1996 Dec;24(4):339-41. No abstract available.

PMID:
9088550
50.

Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.

Kaplan G, Totsuka A, Thompson P, Akatsuka T, Moritsugu Y, Feinstone SM.

EMBO J. 1996 Aug 15;15(16):4282-96.

Supplemental Content

Loading ...
Support Center